Quest Diagnostics Gross Profit 2010-2024 | DGX

Quest Diagnostics annual/quarterly gross profit history and growth rate from 2010 to 2024. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
  • Quest Diagnostics gross profit for the quarter ending March 31, 2024 was $0.771B, a 0% increase year-over-year.
  • Quest Diagnostics gross profit for the twelve months ending March 31, 2024 was $3.053B, a 5.74% decline year-over-year.
  • Quest Diagnostics annual gross profit for 2023 was $3.053B, a 11.07% decline from 2022.
  • Quest Diagnostics annual gross profit for 2022 was $3.433B, a 18.44% decline from 2021.
  • Quest Diagnostics annual gross profit for 2021 was $4.209B, a 15.85% increase from 2020.
Quest Diagnostics Annual Gross Profit
(Millions of US $)
2023 $3,053
2022 $3,433
2021 $4,209
2020 $3,633
2019 $2,689
2018 $2,605
2017 $2,683
2016 $2,598
2015 $2,836
2014 $2,798
2013 $2,820
2012 $3,018
2011 $3,029
2010 $2,985
2009 $3,134
Quest Diagnostics Quarterly Gross Profit
(Millions of US $)
2024-03-31 $771
2023-12-31 $736
2023-09-30 $754
2023-06-30 $792
2023-03-31 $771
2022-12-31 $758
2022-09-30 $868
2022-06-30 $842
2022-03-31 $965
2021-12-31 $1,026
2021-09-30 $1,104
2021-06-30 $985
2021-03-31 $1,094
2020-12-31 $1,269
2020-09-30 $1,206
2020-06-30 $606
2020-03-31 $552
2019-12-31 $662
2019-09-30 $692
2019-06-30 $688
2019-03-31 $647
2018-12-31 $604
2018-09-30 $667
2018-06-30 $676
2018-03-31 $658
2017-12-31 $671
2017-09-30 $666
2017-06-30 $694
2017-03-31 $652
2016-12-31 $400
2016-09-30 $728
2016-06-30 $751
2016-03-31 $719
2015-12-31 $699
2015-09-30 $718
2015-06-30 $743
2015-03-31 $676
2014-12-31 $699
2014-09-30 $726
2014-06-30 $728
2014-03-31 $645
2013-12-31 $705
2013-09-30 $699
2013-06-30 $721
2013-03-31 $695
2012-12-31 $701
2012-09-30 $741
2012-06-30 $776
2012-03-31 $800
2011-12-31 $716
2011-09-30 $790
2011-06-30 $799
2011-03-31 $725
2010-12-31 $677
2010-09-30 $773
2010-06-30 $796
2010-03-31 $739
2009-12-31 $778
2009-09-30 $800
2009-06-30 $802
2009-03-31 $755
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $15.759B $9.252B
Quest Diagnostics, Inc. is the provider of commercial laboratory services. Quest provides lab testing services to physicians, hospitals, managed care organizations, employers, government institutions and other clinical laboratories. The company consists of 2 business groups - Diagnostic Information Services and Diagnostic Solutions. The company's focus is on two elements - to accelerate growth and to drive operational excellence. Restore Growth: The company has adopted seven tactical approaches to accelerate growth such as sales and marketing; development of esoteric testing through a disease focus; partnerships with hospitals and successful testing of international IDNs; creation of value from information assets; leadership in companion diagnostics; extension into adjacent markets. Drive Operational excellence: The company plans to focus on four strategic requirements - to enhance end-to-end customer value chain, enterprise information technology architecture, business performance tools and cost excellence.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $16.733B 10.12
DaVita (DVA) United States $11.818B 14.68
Encompass Health (EHC) United States $8.593B 22.00
Chemed (CHE) United States $8.450B 26.19
Elanco Animal Health (ELAN) United States $8.367B 21.70
Option Care Health (OPCH) United States $5.046B 19.10
RadNet (RDNT) United States $4.290B 89.34
Amedisys (AMED) United States $3.162B 22.40
LifeStance Health (LFST) United States $2.221B 0.00
Astrana Health (ASTH) United States $2.135B 28.86
Addus HomeCare (ADUS) United States $1.805B 25.82
U.S Physical Therapy (USPH) United States $1.554B 41.57
Pennant (PNTG) United States $0.695B 36.71
Aveanna Healthcare Holdings (AVAH) United States $0.543B 0.00
Atai Life Sciences (ATAI) Germany $0.280B 0.00
Daxor (DXR) United States $0.045B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.028B 0.00
ATI Physical Therapy (ATIP) United States $0.022B 0.00
Psychemedics (PMD) United States $0.015B 0.00
Ontrak (OTRK) United States $0.013B 0.00
Novo Integrated Sciences (NVOS) United States $0.009B 0.00
IMAC Holdings (BACK) United States $0.004B 0.00